SinoMab Bioscience Ltd. (HK:3681)
:3681
Want to see HK:3681 full AI Analyst Report?
Total Valuation
SinoMab Bioscience Ltd. has a market cap or net worth of HK$2.06B. The enterprise value is HK$1.50B.
Market CapHK$2.06B
Enterprise ValueHK$1.50B
Share Statistics
SinoMab Bioscience Ltd. has 1,386,638,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,386,638,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
SinoMab Bioscience Ltd.’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -14.73%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-14.73%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee0.00
Profits Per Employee-1.11M
Employee Count95
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of SinoMab Bioscience Ltd. is ―. SinoMab Bioscience Ltd.’s PEG ratio is 0.28.
PE Ratio―
PS Ratio0.00
PB Ratio2.91
Price to Fair Value2.91
Price to FCF-15.42
Price to Operating Cash Flow-24.27
PEG Ratio0.28
Income Statement
In the last 12 months, SinoMab Bioscience Ltd. had revenue of 0.00 and earned -102.27M in profits. Earnings per share was -0.08.
Revenue0.00
Gross Profit0.00
Operating Income-124.70M
Pretax Income-102.27M
Net Income-102.27M
EBITDA-124.70M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -73.78M and capital expenditures -12.07M, giving a free cash flow of -85.85M billion.
Operating Cash Flow-73.78M
Free Cash Flow-85.85M
Free Cash Flow per Share-0.06
Dividends & Yields
SinoMab Bioscience Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change-3.85%
50-Day Moving Average1.77
200-Day Moving Average1.94
Relative Strength Index (RSI)39.82
Average Volume (3m)6.26M
Important Dates
SinoMab Bioscience Ltd. upcoming earnings date is Aug 24, 2026, TBA (Not Confirmed).
Last Earnings DateMar 23, 2026
Next Earnings DateAug 24, 2026
Ex-Dividend Date―
Financial Position
SinoMab Bioscience Ltd. as a current ratio of 1.91, with Debt / Equity ratio of 66.65%
Current Ratio1.91
Quick Ratio1.91
Debt to Market Cap0.23
Net Debt to EBITDA-0.04
Interest Coverage Ratio-23.16
Taxes
In the past 12 months, SinoMab Bioscience Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
SinoMab Bioscience Ltd. EV to EBITDA ratio is -11.89, with an EV/FCF ratio of -15.47.
EV to Sales0.00
EV to EBITDA-11.89
EV to Free Cash Flow-15.47
EV to Operating Cash Flow-21.03
Balance Sheet
SinoMab Bioscience Ltd. has HK$382.40M in cash and marketable securities with HK$338.64M in debt, giving a net cash position of HK$43.76M billion.
Cash & Marketable SecuritiesHK$382.40M
Total DebtHK$338.64M
Net CashHK$43.76M
Net Cash Per ShareHK$0.03
Tangible Book Value Per ShareHK$0.41
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for SinoMab Bioscience Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast50.29%